The novel SRSF3 inhibitor, SFI003, demonstrated strong antitumor efficacy both in vitro and in vivo, inducing apoptosis in CRC cells via the SRSF3/DHCR24/ROS pathway [142]. The gene discussed is SRSF3; the disease is colorectal carcinoma.